| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
1e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.18 |
4e-05 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
| mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
6e-05 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.18 |
7e-05 |